therapeutic testosterone

DRUG4 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Alliance for Clinical Trials in Oncology, City of Hope Medical Center, Roswell Park Cancer Institute

Conditions

Breast CancerCancer SurvivorLocalized Prostate CarcinomaProstate CancerSexual DysfunctionSexuality and Reproductive IssuesStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8

Phase 1

Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy

CompletedNCT00006044

Memorial Sloan Kettering Cancer CenterProstate Cancer

Start: 2000-02-29Updated: 2013-01-18

Phase 2

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

Active, not recruitingNCT00080756

City of Hope Medical Centerbrca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer

Start: 2004-03-11End: 2024-10-15Updated: 2024-08-28

Phase 3

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

CompletedNCT00075855

Alliance for Clinical Trials in OncologyCancer Survivor, Sexual Dysfunction, Sexuality and Reproductive Issues +1

Start: 2004-04-30End: 2007-10-31Updated: 2016-07-13

Phase 4

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

SuspendedNCT06733350

Roswell Park Cancer InstituteLocalized Prostate Carcinoma, Stage III Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 +1

Start: 2025-01-15End: 2029-01-15Target: 600Updated: 2026-02-09

Related Papers

Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.

2009-04-0361 citations